Is a complete ACHV research report available?

No complete published report is available for Achieve Life Sciences, Inc. (ACHV) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Achieve Life Sciences, Inc. (ACHV)

NASDAQ: ACHV · USD

$6.30

+0.12 (+1.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ACHV analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	646.8M
Net income (ttm)	-52M
EPS (ttm)	-$1.08
Shares out	102.7M
Volume	828,974
Beta	2.22
Price target	$13.8	+119.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -52M
EPS (ttm): -$1.08
Market cap: 646.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ACHV indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

USD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000949858
Company name	Achieve Life Sciences, Inc.
Country	United States
Country code	US
Cusip	004468500
Employees	28
Employees Change	3%
Employees Change Percent	12
Enterprise value	$632.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US0044685008
Last refreshed	2026-07-31
Market cap	$646.8M
Market cap category	Small-Cap
Price	$6.3
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2835
Symbol	ACHV
Website	https://www.achievelifesciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.04%
EV Sales Forward	229.54x
FCF yield	-7.01%
P/B ratio	31.41x
PS Forward	234.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-52M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-1.9M
ROA	-108.4
Roa5y	-70.29
ROCE	-244.7
ROE	-496.1
Roe5y	-374.3
ROIC	-142.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	147.21%
Cagr3y	4%
Cagr5y	-2.74%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$33.1M
Cash	$29.3M
Current Assets	$31.1M
Current Liabilities	$11.8M
Debt	$15M
Debt Equity	$1.4
Equity	$10.7M
Interest Coverage	-57.33
Liabilities	$22.4M
Long Term Assets	$2M
Long Term Liabilities	$10.6M
Net Cash	$14.3M
Net Cash By Market Cap	$2.21
Net Cash Growth	7.77%
Net Debt Equity	$-1.34
Tangible Book Value	$8.9M
Tangible Book Value Per Share	$0.17
WACC	16.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.62
Net Working Capital	$-4.4M
Quick ratio	2.47
Working Capital	$19.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-39.99%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	147.06%
200-day SMA	4.76
3Y total return	12.5%
50-day SMA	5.69
50-day SMA vs 200-day SMA	50over200
5Y total return	-12.98%
All Time High	1,053.7
All Time High Change	-99.4%
All Time High Date	2017-08-02
All Time Low	1.84
All Time Low Change	242.39%
All Time Low Date	2025-04-09
ATR	0.4
Beta	2.22
Beta1y	4.28
Beta2y	2.55
Ch YTD	26.76
High	6.34
High52	7.11
High52 Date	2026-07-01
High52ch	-11.39%
Low	6.08
Low52	2.37
Low52 Date	2025-08-12
Low52ch	165.71%
Ma50ch	10.68%
Premarket Change Percent	1.38
Premarket Price	$6.26
Premarket Volume	771
Price vs 200-day SMA	32.44%
RSI	56.06
RSI Monthly	55.13
RSI Weekly	61.98
Sharpe ratio	1.39x
Sortino ratio	2.46
Total Return	-39.99%
Tr YTD	26.76
Tr1m	1.12%
Tr1w	2.11%
Tr3m	51.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	3
Analyst Price Target Top	$17
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.16
Operating Income	$-52.4M
Price target	$13.8
Price Target Change	$119
Price Target Change Top	$170

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	87,466,168%
Float Percent	85.2%
Net Borrowing	5,000,000
Shares Insiders	2.34%
Shares Institutions	41.26%
Shares Out	102,659,057
Shares Qo Q	0.2%
Shares Yo Y	39.99%
Short Float	16.84%
Short Ratio	5.18
Short Shares	14.35

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-51.2M
Adjusted OCF	-51,153,000
Average Volume	1,375,355x
Bv Per Share	0.2
CAPEX	$-3,000
Ch1m	1.12
Ch1w	2.11
Ch1y	147.1
Ch3m	51.81
Ch3y	12.5
Ch5y	-12.98
Ch6m	45.16
Change	1.94%
Change From Open	1.45
Close	6.18
Days Gap	0.49
Depreciation Amortization	223,000
Dollar Volume	5,222,536.2
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-52.1M
EBITDA	$-51.8M
EPS	$-1.08
F Score	1
FCF	$-45.3M
FCF EV Yield	-7.16x
FCF Per Share	$-0.44
Financing CF	51,548,000
Fiscal Year End	December
Goodwill	1,034,000
Investing CF	9,034,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Date	2020-07-31
Last Split Type	Reverse
Last10k Filing Date	2026-03-24
Ma150	4.84
Ma150ch	30.25%
Ma20	6.26
Ma20ch	0.62%
Net CF	15,277,000
Next Earnings Date	2026-08-10
Open	6.21
Optionable	Yes
Position In Range	84.62
Post Close	6.3
Postmarket Change Percent	-0.16
Postmarket Price	$6.29
Ppne	49,000
Pre Close	6.18
Price Date	2026-07-30
Ptbv Ratio	72.28
Relative Volume	0.6x
Share Based Comp	5,844,000
Tr6m	45.16%
Us State	Washington
Volume	828,974

Achieve Life Sciences, Inc. (ACHV)

Coverage state: Market snapshot only — no published research

Generate the first ACHV analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ACHV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ACHV indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ACHV

Frequently asked questions